Investment
Why institutional real estate investors are turning to medtech
Real estate investors like having medtech companies as tenants.
8 min read
Table of Contents
Written by
More from Life Sciences Real Estate
paid
Medtech companies and their real estate
European medtech companies navigate complex real estate decisions across innovation clusters, balancing flexibility needs with regulatory requirements.
5 min read
paid
Niche sector, strong momentum: life sciences' growing share of the UK commercial property market
Life sciences real estate is a specialised segment expanding at a speed that outpaces most traditional property sectors.
4 min read
paid
How CROs and CDMOs navigate real estate decisions
Life science contract organisations balance real estate ownership (73 per cent) vs leasing (27 per cent) based on financial, operational, and strategic considerations.
5 min read